Company intelligence / Profile preview

Epygon

Colleretto Giacosa, Piedmont/Turin province ("TO"), Italyaffluentmedical.com ↗

Ownership: Private
Employees: ~25
Development stage: Clinical

Overview

Epygon has developed a novel mitral bioprosthetic cardiac valve designed for minimally invasive transcatheter implantation. The device aims to closely mimic the physiological function of the native mitral valve, featuring a D-shape, monoleaflet design, and asymmetric profile to optimize fit and hemodynamics. As of now, it remains in pre-clinical development with internal manufacturing of prototypes; next steps include first-in-human studies and CE mark application[5].

Therapeutic areas: Cardiovascular
Modalities: Device (bioprosthetic cardiac valve)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Epygon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epygon.

Explore the full profile